Pro Publica’s investigation into Zofran usage by pregnant women is a much-needed critical examination of pharmaceutical usage during pregnancy.
Zofran, and other drugs, have been prescribed even though they have not yet received F.D.A. approval for their intended use. Reporter Nina Martin exposes this practice of prescribing “off label” drugs. Too often, we see the tragic results when clients call upon us to find out whether they can file a lawsuit against the makers of Zofran and other drugs. Read this excellent expose in its entirety.